Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q3 2026 Earnings

6AugConfirmed

Q3 2025

Q4 2025

Q2 2026

Next

-0.76

-0.56

-0.35

-0.15

Details

Expected EPS

-0.758855

Actual EPS

N/A

Surprise EPS

0.76

Surprise Percent

+100%

Description

Spyre Therapeutics (SYRE) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.